Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [908]

Thoracic radiotherapy in extensive stage small cell lung cancer improved...

Dr Corinne Faivre-Finn - The Christie, Manchester, UK

Thoracic radiotherapy in extensive stage small cell lung cancer improved survival ( Dr Corinne Faivre-Finn - The Christie, Manchester, UK )

Multidisciplinary approach to oncology improves accuracy of lung cancer...

Prof Peter Kuhn - University of Southern California, Los Angeles, USA

Multidisciplinary approach to oncology improves accuracy of lung cancer screening ( Prof Peter Kuhn - University of Southern California, Los Angeles, USA )

Managing strategies for lung, head and neck cancer

Dr William Nassib William Junior – MD Anderson, Houston, TX, USA

Managing strategies for lung, head and neck cancer ( Dr William Nassib William Junior – MD Anderson, Houston, TX, USA )

ESMO 2014: News Roundup

ecancer News Team

ESMO 2014: News Roundup ( ecancer News Team )

ESMO 2014 Editor's roundup

Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy

ESMO 2014 Editor's roundup ( Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy )

Prognostic biomarkers will detect lung cancer at earlier stages

Prof Giulia Veronesi - European Institute of Oncology, Milan, Italy

Prognostic biomarkers will detect lung cancer at earlier stages ( Prof Giulia Veronesi - European Institute of Oncology, Milan, Italy )

Questions raised about the future of lung cancer vaccination?

Prof Johan Vansteenkiste - University Hospital Leuven, Leuven, Belgium

Questions raised about the future of lung cancer vaccination? ( Prof Johan Vansteenkiste - University Hospital Leuven, Leuven, Belgium )

PD-L1 protein a possible immunotherapy target in mesothelioma

Prof Rolf Stahel - University Hospital of Zurich, Zurich, Switzerland

PD-L1 protein a possible immunotherapy target in mesothelioma ( Prof Rolf Stahel - University Hospital of Zurich, Zurich, Switzerland )

Phase III trial results raise questions about the future of lung cancer...

Prof Johan Vansteenkiste - University Hospital Leuven, Leuven, Belgium

Phase III trial results raise questions about the future of lung cancer vaccination ( Prof Johan Vansteenkiste - University Hospital Leuven, Leuven, Belgium )

Little benefit for gefitinib-resistant lung cancer when continuing the drug...

Dr Tony Mok - The Chinese University of Hong Kong, Shatin, China

Little benefit for gefitinib-resistant lung cancer when continuing the drug with chemotherapy ( Dr Tony Mok - The Chinese University of Hong Kong, Shatin, China )

Anamorelin improves appetite and body mass in non-small cell lung cancer with...

Dr David Currow - Flinders University, Adelaide, Australia

Anamorelin improves appetite and body mass in non-small cell lung cancer with cancer anorexia-cachexia ( Dr David Currow - Flinders University, Adelaide, Australia )

New drug anamorelin shows improvement in appetite and body mass in non-small...

Prof David Currow - Flinders University, Adelaide, Australia

New drug anamorelin shows improvement in appetite and body mass in non-small cell lung cancer with cancer anorexia-cachexia ( Prof David Currow - Flinders University, Adelaide, Australia )

More from ecancer